These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12110988)

  • 21. Nicotine: from molecular mechanisms to behaviour.
    Wonnacott S; Sidhpura N; Balfour DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):53-9. PubMed ID: 15661626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognising nicotine: the neurobiological basis of nicotine discrimination.
    Smith JW; Stolerman IP
    Handb Exp Pharmacol; 2009; (192):295-333. PubMed ID: 19184654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurochemical and behavioral studies on ethanol and nicotine interactions.
    Larsson A; Engel JA
    Neurosci Biobehav Rev; 2004 Jan; 27(8):713-20. PubMed ID: 15019421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
    David SP; Niaura R; Papandonatos GD; Shadel WG; Burkholder GJ; Britt DM; Day A; Stumpff J; Hutchison K; Murphy M; Johnstone E; Griffiths SE; Walton RT
    Nicotine Tob Res; 2003 Dec; 5(6):935-42. PubMed ID: 14668077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An analysis of the addiction liability of nicotine.
    Collins AC
    Adv Alcohol Subst Abuse; 1990; 9(1-2):83-101. PubMed ID: 2198787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of nicotine in smoking: a dual-reinforcement model.
    Caggiula AR; Donny EC; Palmatier MI; Liu X; Chaudhri N; Sved AF
    Nebr Symp Motiv; 2009; 55():91-109. PubMed ID: 19013940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuropharmacology of smoking: basic research opens new therapeutic possibilities].
    Svensson TH; Grenhoff J
    Lakartidningen; 1991 May; 88(22):2066-71. PubMed ID: 2051876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Round table on nicotinic receptors in addiction: summary report.
    Domino EF
    Eur J Pharmacol; 2000 Mar; 393(1-3):315-20. PubMed ID: 10771026
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders.
    Balfour DJ; Fagerström KO
    Pharmacol Ther; 1996; 72(1):51-81. PubMed ID: 8981571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The opioid receptors as targets for drug abuse medication.
    Noble F; Lenoir M; Marie N
    Br J Pharmacol; 2015 Aug; 172(16):3964-79. PubMed ID: 25988826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug addiction.
    Camí J; Farré M
    N Engl J Med; 2003 Sep; 349(10):975-86. PubMed ID: 12954747
    [No Abstract]   [Full Text] [Related]  

  • 33. A multi-route model of nicotine-cotinine pharmacokinetics, pharmacodynamics and brain nicotinic acetylcholine receptor binding in humans.
    Teeguarden JG; Housand CJ; Smith JN; Hinderliter PM; Gunawan R; Timchalk CA
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):12-28. PubMed ID: 23099439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological aspects of the link between smoking and depression.
    Quattrocki E; Baird A; Yurgelun-Todd D
    Harv Rev Psychiatry; 2000 Sep; 8(3):99-110. PubMed ID: 10973935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation, withdrawal, and nicotine addiction.
    Schachter S
    NIDA Res Monogr; 1979 Jan; (23):123-33. PubMed ID: 111132
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurobiological Bases of Cue- and Nicotine-induced Reinstatement of Nicotine Seeking: Implications for the Development of Smoking Cessation Medications.
    Stoker AK; Markou A
    Curr Top Behav Neurosci; 2015; 24():125-54. PubMed ID: 25638336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotine as a discriminative stimulus to behavior: its characterization and relevance to smoking behavior.
    Rosecrans JA
    NIDA Res Monogr; 1979 Jan; (23):58-69. PubMed ID: 111141
    [No Abstract]   [Full Text] [Related]  

  • 38. [Molecular neurobiological research in the fight against drug abuse].
    Terenius L
    Lakartidningen; 1991 Jul; 88(30-31):2526-30. PubMed ID: 1650871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid receptors in dopaminoceptive neurons, key for cocaine, are dispensable for molecular and behavioral morphine responses.
    Barik J; Parnaudeau S; Saint Amaux AL; Guiard BP; Golib Dzib JF; Bocquet O; Bailly A; Benecke A; Tronche F
    Biol Psychiatry; 2010 Aug; 68(3):231-9. PubMed ID: 20554270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tobacco dependence: is nicotine rewarding or aversive?
    Russell MA
    NIDA Res Monogr; 1979 Jan; (23):100-22. PubMed ID: 111131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.